Monday, September 26, 2016

Today’s articles on Sectors

High Dividend Stock Yields 11%, Record Earnings, Revenue, Cash Flow
By Double Dividend Stocks • 13 comments
Omega Healthcare Investors - The Best Risk Adjusted Income Vehicle I Can Find
By Williams Equity Research • 10 comments
Why Bank Of America Changed How It Accounts For MBS
By Quinn Foley • 14 comments
Editors' Picks
Franklin Resources: Weighing The Good With The Bad
By Eli Inkrot
Investing For The Long Run
By Brad Thomas
Netflix Has A Great Merchandising Opportunity With 'Stranger Things'
By Steven Mallas
A Pure Play Multifamily REIT That's Poised To Profit
By Brad Thomas
'The Monster Is In The Truck!' - A Rangeley Capital Portfolio Manager Discussion
By Chris DeMuth Jr.
More Editors' Picks»

Basic Materials
Transocean: It's Tough Being Patient by Brandon Dempster
The Future Just Got Brighter For Freeport-McMoRan by Alpha Shark
Ensco: Don't Lose Hope by Fundamental Investing
Don't Miss The Opportunity In Crescent Point Energy by Alpha Investor
Will The 'Permian Charm' Work For Encana? by Richard Zeits
More Basic Materials»
Conglomerates
Danaher: A Solid Blue Chip Stock For Value Investors by Aleksey Razdolgin
More Conglomerates»

Consumer Goods
Why GoPro's Stock Will Fly Higher by Chris Lau
Ford Motor: I Am Reducing My Short-Term Price Target To $11 by Achilles Research
Boosting Ford's Performance With Options by FerdiS
Is Nike Under Assault? by Stone Fox Capital
Karma Drone Was Long Overdue, But It Was Worth The Wait by Samuel Harrison
More Consumer Goods»
Financial
Delaying Discovery May Come With Sanctions - Fannie And Freddie Lawsuits by Glen Bradford
ING Looks Intriguing Here by FIG Ideas
Aimco: Is There Hidden Value In This REIT? by Michael Boyd
How Ansell's Protection Solutions Could Benefit Your Portfolio by Ivory Wolf
Financial Review Of The Debt Structure Of The 5 Biggest Triple Net Lease REITs by Robin Nieland
More Financial»
Healthcare
Gilead Remains A Wild Card As Long As It Isn't Buying Anyone by Abba's Aces
MannKind: Afrezza Scripts Approach 300; Trajectory Is Still Low by Spencer Osborne
Amgen's New Products Have Ample Insurance Coverage In The U.S. by Clinically Sound Investor
Quintiles Transnational: A Total Return Growth Biopharmaceutical (Part 7 Single Letter Symbol Companies) by William Stamm
Syros Pharmaceuticals: Capitalize On This Gene Control First Mover by Jonathan Faison
More Healthcare»
Industrial Goods
Chicago Bridge & Iron's Cash Cow by Daniel Jones
Saudia Backs Boeing 777-300ER by Dhierin Bechai
More Industrial Goods»
Services
Can One Justify Paying A P/E Of 30 For Starbucks by Tolga Kuru
Whole Foods Market: The Weakness Is An Opportunity by Alpha Investor
Kroger: Moving Ahead Despite Challenges by Horizon Investments
FedEx Results Signal Continued Status Quo In A Low-Growth Environment by James Sands
MercadoLibre: Two Of The Best Trends In The Market In One Stock by Bill Gunderson
More Services»
Technology
Cisco Covered Calls? Here Are 4 Better Options For Income Investors by Blue Harbinger
Microsoft Launches Subscription-Based LinkedIn Learning Skills Training Service by Motek Moyen
Can Apple Get The iPad Going Again? by Bill Maurer
Citrix: Getting To Know A Complicated Company by Bert Hochfeld
Airgain Is One To Watch In 2017 by Michael Minicilli
More Technology»

Please do not forward this email. It allows direct access to your Seeking Alpha Portfolio.

Why are you receiving this? You subscribed to Sectors at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017

No comments:

Post a Comment

Gimme your 2 cents!

Banner Ad